Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition:   Toxic Epidermal NecrolysisIntervention:   Drug: Clobetasol 0.05% ointmentSponsor:   University of California, DavisNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2014 Category: Research Source Type: clinical trials

Clobetasol for Oral Graft-Versus-Host Disease
Condition:   Oral Chronic Graft vs Host DiseaseInterventions:   Drug: Clobetasol Oral Rinse;   Drug: Placebo oral rinseSponsors:   National Cancer Institute (NCI);   National Institutes of Health Clinical Center (CC)Recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2012 Category: Research Source Type: clinical trials

Clobetasol for Oral Graft-Versus-Host Disease
Condition:   Oral Chronic Graft vs Host DiseaseInterventions:   Drug: Clobetasol Oral Rinse;   Drug: Placebo oral rinseSponsors:   National Cancer Institute (NCI);   National Institutes of Health Clinical Center (CC)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2012 Category: Research Source Type: clinical trials

Clobetasol for Oral Graft-Versus-Host Disease
Condition:   Oral Chronic Graft vs Host DiseaseInterventions:   Drug: Clobetasol Oral Rinse;   Drug: Placebo oral rinseSponsor:   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2012 Category: Research Source Type: clinical trials

Clobetasol for Oral Graft-Versus-Host Disease
Condition:   Oral Chronic Graft vs Host DiseaseInterventions:   Drug: Clobetasol Oral Rinse;   Drug: Placebo oral rinseSponsors:   National Cancer Institute (NCI);   National Institutes of Health Clinical Center (CC)Recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2012 Category: Research Source Type: clinical trials

Clobetasol for Oral Graft-Versus-Host Disease
Condition:   Oral Chronic Graft vs Host DiseaseInterventions:   Drug: Clobetasol Oral Rinse;   Drug: Placebo oral rinseSponsor:   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2012 Category: Research Source Type: clinical trials